人工智能重塑疫苗研发新范式:效率革命与精准设计OA
Artificial intelligence reshaping vaccine development:a new paradigm of efficiency revolution and precision design
人工智能(artificial intelligence,AI)通过整合深度学习架构与多组学数据,正在系统性地重塑疫苗研发全链条,推动其从传统依赖试错的"经验驱动"模式,向以"数据驱动"和"算法生成"为核心的理性设计新范式转型.尽管面临数据异质性、模型"黑箱"、算法偏见以及监管框架滞后等多重挑战,AI技术通过与免疫机理的深度结合,推动疫苗设计从"结构模拟"向"功能创造"跨越,为疫苗研发提供了全新范式.本综述系统梳理了AI在疫苗研发多个关键环节的创新应用与典型进展,包括疫苗靶标挖掘、抗原设计、疫苗佐剂、工艺开发、临床试验、疫苗犹豫等,尤其汇总了近年来用于疫苗理性设计的相关工具、核心架构、主要特点和典型案例,为后续疫苗开发中AI技术的应用提供借鉴.
Artificial intelligence(AI)is systematically reshaping the entire vaccine research and development pipeline through integrating deep learning architectures with multi-omics data.This facilitates a paradigm shift from traditional trial-and-error empirical approaches to a novel rational design framework centered on data-driven and algorithm-generated methodologies.Despite challenges including data heterogeneity,model opacity,algorithmic bias,and lagging regulatory frameworks,AI enables a transformative leap from structural mimicry to functional innovation in vaccine design via deep integration with immunological mechanisms.This review comprehensively analyzes AI applications across key vaccine development stages:target identification,antigen design,adjuvant screening,process optimization,clinical trial design,and vaccine hesitancy mitigation.We particularly summarize recent tools,core architectures,functional features,and representative cases for AI-powered rational vaccine design,providing actionable references for future AI implementation in vaccinology.
顾江;李宇航
陆军军医大学(第三军医大学)药学与检验医学系国家免疫生物制品工程技术研究中心,重庆陆军军医大学(第三军医大学)药学与检验医学系国家免疫生物制品工程技术研究中心,重庆
医药卫生
人工智能深度学习疫苗佐剂
artificial intelligencedeep learningvaccineadjuvants
《陆军军医大学学报》 2026 (4)
387-393,7
Supported by the National Key Research and Development Program of China(2024YFC2310801)and the Projoet of Higher Education Teaching Reform Research of Chongqing(233584). 国家重点研发计划(2024YFC2310801)重庆市高等教育教学改革研究项目(233584)
评论